Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director · President and CEO | September 29, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date September 29, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 384,885 |
Reported balance
After 2026-09-29 transaction · row 1
1 source rowRow 1 · 2026-09-29 · Purchase · Acquired 1,000 · Balance 384,885 F1: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2026 Filed Oct 1, 2026 02:51 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $1.03 | $1,030.00 |
DisclosureSEC source: 0001437749-26-031638 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,885 F1 · shares: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.02 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| September 23, 2026 Filed Sep 24, 2026 00:14 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,900 | $1.05 | $1,995.00 |
DisclosureSEC source: 0001437749-26-031093 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,885 F1 · shares: This transaction was executed in multiple trades ranging from $1.04 to $1.08 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.04 to $1.08 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| September 03, 2026 Filed Sep 5, 2026 01:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 800 | $1.09 | $872.00 |
DisclosureSEC source: 0001437749-26-029732 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,985 F1 · shares: This transaction was executed in multiple trades ranging from $1.09 to $1.10 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.09 to $1.10 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · balance_after: The total herein has been corrected by adding 70 shares that were inadvertently omitted from the Form 4 filed August 18, 2026. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 16:14 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,400 | $0.93 | $5,022.00 |
DisclosureSEC source: 0001437749-26-028307 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,115 F1 · shares: This transaction was executed in multiple trades ranging from $0.92 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.92 to $0.97 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| August 13, 2026 Filed Aug 13, 2026 21:43 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,900 | $0.92 | $1,748.00 |
DisclosureSEC source: 0001437749-26-027743 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,785 F1 · shares: This transaction was executed in multiple trades ranging from $0.89 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.89 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 01:05 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $0.78 | $3,900.00 |
DisclosureSEC source: 0001437749-26-024925 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,885 F1 · shares: This transaction was executed in multiple trades ranging from $0.77 to $0.80 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.77 to $0.80 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 20:16 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 500 | $0.83 | $415.00 |
DisclosureSEC source: 0001437749-26-023868 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,885 Read SEC document |
| July 15, 2026 Filed Jul 15, 2026 20:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,500 | $0.86 | $1,290.00 |
DisclosureSEC source: 0001437749-26-023637 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,385 F2 · shares: This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| July 14, 2026 Filed Jul 15, 2026 20:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 2,800 | $0.88 | $2,464.00 |
DisclosureSEC source: 0001437749-26-023637 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,885 F1 · shares: This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.86 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| July 10, 2026 Filed Jul 10, 2026 22:18 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $0.94 | $940.00 |
DisclosureSEC source: 0001437749-26-023365 · rdgdoc.xml · nonDerivative · entry 3 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,485 Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 22:18 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,000 | $0.90 | $900.00 |
DisclosureSEC source: 0001437749-26-023365 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,485 Read SEC document |
| July 08, 2026 Filed Jul 8, 2026 19:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,400 | $0.96 | $5,208.30 |
DisclosureSEC source: 0001437749-26-023016 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,985 F1 · shares: This transaction was executed in multiple trades ranging from $0.92 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.92 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 22:18 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,500 | $0.97 | $5,335.00 |
DisclosureSEC source: 0001437749-26-023365 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,485 F1 · shares: This transaction was executed in multiple trades ranging from $0.92 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.92 to $1.05 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 02:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 57,688 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001437749-26-022969 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,903 Underlying: Common stock · 57,688 shares Expires 2036-07-06 F2 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| July 02, 2026 Filed Jul 8, 2026 02:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | Tax withholdingCommon Stock | 54,606 | $1.24 | $67,711.44 |
DisclosureSEC source: 0001437749-26-022969 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 356,585 F1 · shares: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. F1 · price: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:37 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 110,625 | $1.20 | $132,750.00 |
DisclosureSEC source: 0001437749-26-022365 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,191 F1 · shares: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026. F1 · price: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on June 29, 2026. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 10:09 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 800 | $0.96 | $768.00 |
DisclosureSEC source: 0001437749-26-021216 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,566 F2 · shares: This transaction was executed in multiple trades ranging from $0.98 to $0.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $0.98 to $0.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 10:09 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,500 | $0.85 | $1,275.00 |
DisclosureSEC source: 0001437749-26-021216 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,766 F1 · shares: This transaction was executed in multiple trades ranging from $0.84 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.84 to $0.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 09, 2026 Filed Jun 9, 2026 21:37 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $0.85 | $4,250.00 |
DisclosureSEC source: 0001437749-26-020044 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,266 Read SEC document |
| May 20, 2026 Filed May 21, 2026 22:14 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,500 | $0.92 | $1,380.00 |
DisclosureSEC source: 0001437749-26-018125 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,266 F2 · shares: This transaction was executed in multiple trades ranging from $0.91 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $0.91 to $0.95 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 19, 2026 Filed May 21, 2026 22:14 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 200 | $0.95 | $190.00 |
DisclosureSEC source: 0001437749-26-018125 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,766 F1 · shares: This transaction was executed in multiple trades ranging from $0.9506 to $0.9508 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.9506 to $0.9508 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 18, 2026 Filed May 19, 2026 00:20 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,700 | $0.92 | $5,244.00 |
DisclosureSEC source: 0001437749-26-017672 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,566 F1 · shares: This transaction was executed in multiple trades ranging from $0.89 to $1.02 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $0.89 to $1.02 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 15, 2026 Filed May 15, 2026 21:46 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,100 | $1.02 | $5,202.00 |
DisclosureSEC source: 0001437749-26-017459 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,866 F1 · shares: This transaction was executed in multiple trades ranging from $1.01 to $1.03 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.01 to $1.03 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 29, 2026 Filed Apr 29, 2026 23:40 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $1.11 | $5,550.00 |
DisclosureSEC source: 0001437749-26-013944 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,766 Read SEC document |
| April 21, 2026 Filed Apr 22, 2026 21:04 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 400 | $1.23 | $492.00 |
DisclosureSEC source: 0001437749-26-013052 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,766 F2 · shares: This transaction was executed in multiple trades ranging from $1.21 to $1.24 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.21 to $1.24 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| April 20, 2026 Filed Apr 22, 2026 21:04 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 600 | $1.23 | $738.00 |
DisclosureSEC source: 0001437749-26-013052 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,366 F1 · shares: This transaction was executed in multiple trades ranging from $1.22 to $1.27 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.22 to $1.27 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 00:05 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 300 | $1.22 | $366.00 |
DisclosureSEC source: 0001437749-26-009986 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,766 F2 · shares: This transaction was executed in multiple trades ranging from $1.19 to $1.25 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.19 to $1.25 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| March 24, 2026 Filed Mar 27, 2026 00:05 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 600 | $1.24 | $744.00 |
DisclosureSEC source: 0001437749-26-009986 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,466 F1 · shares: This transaction was executed in multiple trades ranging from $1.24 to $1.26 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.24 to $1.26 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| February 04, 2026 Filed Feb 4, 2026 22:47 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 5,000 | $1.13 | $5,650.00 |
DisclosureSEC source: 0001437749-26-003027 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,866 Read SEC document |
| January 21, 2026 Filed Jan 21, 2026 22:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 300 | $1.34 | $402.00 |
DisclosureSEC source: 0001437749-26-001643 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,866 F2 · shares: This transaction was executed in multiple trades ranging from $1.34 to $1.35 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.34 to $1.35 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 22:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 600 | $1.32 | $792.00 |
DisclosureSEC source: 0001437749-26-001643 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,566 F1 · shares: This transaction was executed in multiple trades ranging from $1.31 to $1.33 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.31 to $1.33 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| December 17, 2025 Filed Dec 17, 2025 23:32 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 900 | $1.30 | $1,170.00 |
DisclosureSEC source: 0001437749-25-038200 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,966 F1 · shares: This transaction was executed in multiple trades ranging from $1.28 to $1.46 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.28 to $1.46 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| December 16, 2025 Filed Dec 17, 2025 23:32 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 200 | $1.37 | $274.00 |
DisclosureSEC source: 0001437749-25-038200 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,066 F1 · shares: This transaction was executed in multiple trades ranging from $1.28 to $1.46 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.28 to $1.46 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:54 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001437749-25-037475 · rdgdoc.xml · derivative · entry 3 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,215 Underlying: Common stock · 20,000 shares Expires 2035-12-08 F3 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:54 UTC | BioCardia, Inc. BCDA · Entity 7752 | Tax withholdingCommon Stock | 56,484 | $1.37 | $77,383.08 |
DisclosureSEC source: 0001437749-25-037475 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 266,866 F2 · shares: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person. F2 · price: The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:54 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantCommon Stock | 106,588 | $1.37 | $146,025.56 |
DisclosureSEC source: 0001437749-25-037475 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,350 F1 · shares: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025. F1 · price: The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 13:00 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 48,000 | Not disclosed Strike: $1.25 | Not disclosed |
DisclosureSEC source: 0001437749-25-029651 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,612 Underlying: Common Stock · 48,000 shares Expires 2027-09-20 F1 · shares: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 13:00 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 48,000 | $1.25 | $60,000.00 |
DisclosureSEC source: 0001437749-25-029651 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,762 F1 · shares: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| August 22, 2025 Filed Aug 25, 2025 13:30 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 700 | $1.83 | $1,281.00 |
DisclosureSEC source: 0001437749-25-027633 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,762 F1 · shares: This transaction was executed in multiple trades ranging from $1.82 to $1.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.82 to $1.89 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| August 13, 2025 Filed Aug 13, 2025 22:59 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100 | $1.83 | $183.00 |
DisclosureSEC source: 0001437749-25-026614 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,062 F1 · shares: This transaction was executed in a single trade. F1 · price: This transaction was executed in a single trade. Read SEC document |
| August 12, 2025 Filed Aug 12, 2025 23:23 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 400 | $1.75 | $700.40 |
DisclosureSEC source: 0001437749-25-026308 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,962 F1 · shares: This transaction was executed in multiple trades ranging from $1.70 to $1.83 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.70 to $1.83 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| August 11, 2025 Filed Aug 11, 2025 23:21 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,700 | $1.76 | $2,988.60 |
DisclosureSEC source: 0001437749-25-026009 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,562 F1 · shares: This transaction was executed in multiple trades ranging from $1.73 to $1.82 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.73 to $1.82 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:02 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 24,096 | Not disclosed Strike: $1.95 | Not disclosed |
DisclosureSEC source: 0001437749-25-022064 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,612 Underlying: Common Stock · 24,096 shares Expires 2030-06-30 F1 · shares: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| June 30, 2025 Filed Jul 3, 2025 01:02 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 24,096 | $2.08 | $49,999.20 |
DisclosureSEC source: 0001437749-25-022064 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,862 F1 · shares: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| May 30, 2025 Filed May 31, 2025 00:55 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100 | $2.21 | $221.00 |
DisclosureSEC source: 0001437749-25-019036 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,766 F1 · shares: This transaction was executed in a single trade for $2.21 per share. F1 · price: This transaction was executed in a single trade for $2.21 per share. Read SEC document |
| May 22, 2025 Filed May 22, 2025 22:45 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 700 | $1.89 | $1,323.00 |
DisclosureSEC source: 0001437749-25-018235 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,666 F2 · shares: This transaction was executed in multiple trades ranging from $1.87 to $1.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $1.87 to $1.96 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 20, 2025 Filed May 22, 2025 22:45 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 1,600 | $2.08 | $3,328.00 |
DisclosureSEC source: 0001437749-25-018235 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,966 F1 · shares: This transaction was executed in multiple trades ranging from $1.97 to $2.22 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F1 · price: This transaction was executed in multiple trades ranging from $1.97 to $2.22 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 16, 2025 Filed May 16, 2025 21:31 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 300 | $2.43 | $729.60 |
DisclosureSEC source: 0001437749-25-017469 · rdgdoc.xml · nonDerivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,366 F2 · shares: This transaction was executed in multiple trades ranging from $2.409 to $2.448 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. F2 · price: This transaction was executed in multiple trades ranging from $2.409 to $2.448 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price. Read SEC document |
| May 14, 2025 Filed May 16, 2025 21:31 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 100 | $2.99 | $298.60 |
DisclosureSEC source: 0001437749-25-017469 · rdgdoc.xml · nonDerivative · entry 1 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,066 F1 · shares: This transaction was executed in a single trade F1 · price: This transaction was executed in a single trade Read SEC document |
| April 23, 2025 Filed Apr 26, 2025 01:35 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 26,246 | Not disclosed Strike: $1.91 | Not disclosed |
DisclosureSEC source: 0001437749-25-013196 · rdgdoc.xml · derivative · entry 2 Altman Peter · CIK 0001647542 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,516 Underlying: Common Stock · 26,246 shares Expires 2030-04-23 F1 · shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.